These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34190597)

  • 1. Protection of Newborn Macaques by Plant-Derived HIV Broadly Neutralizing Antibodies: a Model for Passive Immunotherapy during Breastfeeding.
    Rosenberg YJ; Jiang X; Cheever T; Coulter FJ; Pandey S; Sack M; Mao L; Urban L; Lees J; Fischer M; Smedley J; Sidener H; Stanton J; Haigwood NL
    J Virol; 2021 Aug; 95(18):e0026821. PubMed ID: 34190597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys.
    Julg B; Pegu A; Abbink P; Liu J; Brinkman A; Molloy K; Mojta S; Chandrashekar A; Callow K; Wang K; Chen X; Schmidt SD; Huang J; Koup RA; Seaman MS; Keele BF; Mascola JR; Connors M; Barouch DH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early antibody therapy can induce long-lasting immunity to SHIV.
    Nishimura Y; Gautam R; Chun TW; Sadjadpour R; Foulds KE; Shingai M; Klein F; Gazumyan A; Golijanin J; Donaldson M; Donau OK; Plishka RJ; Buckler-White A; Seaman MS; Lifson JD; Koup RA; Fauci AS; Nussenzweig MC; Martin MA
    Nature; 2017 Mar; 543(7646):559-563. PubMed ID: 28289286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs.
    Bolton DL; Pegu A; Wang K; McGinnis K; Nason M; Foulds K; Letukas V; Schmidt SD; Chen X; Todd JP; Lifson JD; Rao S; Michael NL; Robb ML; Mascola JR; Koup RA
    J Virol; 2016 Feb; 90(3):1321-32. PubMed ID: 26581981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques.
    Jaworski JP; Kobie J; Brower Z; Malherbe DC; Landucci G; Sutton WF; Guo B; Reed JS; Leon EJ; Engelmann F; Zheng B; Legasse A; Park B; Dickerson M; Lewis AD; Colgin LM; Axthelm M; Messaoudi I; Sacha JB; Burton DR; Forthal DN; Hessell AJ; Haigwood NL
    J Virol; 2013 Oct; 87(19):10447-59. PubMed ID: 23885083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection.
    Wu Y; Xue J; Wang C; Li W; Wang L; Chen W; Prabakaran P; Kong D; Jin Y; Hu D; Wang Y; Lei C; Yu D; Tu C; Bardhi A; Sidorov I; Ma L; Goldstein H; Qin C; Lu L; Jiang S; Dimitrov DS; Ying T
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.
    Julg B; Sok D; Schmidt SD; Abbink P; Newman RM; Broge T; Linde C; Nkolola J; Le K; Su D; Torabi J; Pack M; Pegu A; Allen TM; Mascola JR; Burton DR; Barouch DH
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121.
    Lee WS; Reynaldi A; Amarasena T; Davenport MP; Parsons MS; Kent SJ
    Front Immunol; 2021; 12():749891. PubMed ID: 34867979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.
    Hessell AJ; Rakasz EG; Poignard P; Hangartner L; Landucci G; Forthal DN; Koff WC; Watkins DI; Burton DR
    PLoS Pathog; 2009 May; 5(5):e1000433. PubMed ID: 19436712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent
    Bardhi A; Wu Y; Chen W; Li W; Zhu Z; Zheng JH; Wong H; Jeng E; Jones J; Ochsenbauer C; Kappes JC; Dimitrov DS; Ying T; Goldstein H
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
    Hessell AJ; Shapiro MB; Powell R; Malherbe DC; McBurney SP; Pandey S; Cheever T; Sutton WF; Kahl C; Park B; Zolla-Pazner S; Haigwood NL
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges.
    Gautam R; Nishimura Y; Pegu A; Nason MC; Klein F; Gazumyan A; Golijanin J; Buckler-White A; Sadjadpour R; Wang K; Mankoff Z; Schmidt SD; Lifson JD; Mascola JR; Nussenzweig MC; Martin MA
    Nature; 2016 May; 533(7601):105-109. PubMed ID: 27120156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.
    Haigwood NL; Watson A; Sutton WF; McClure J; Lewis A; Ranchalis J; Travis B; Voss G; Letvin NL; Hu SL; Hirsch VM; Johnson PR
    Immunol Lett; 1996 Jun; 51(1-2):107-14. PubMed ID: 8811353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.
    Haigwood NL; Montefiori DC; Sutton WF; McClure J; Watson AJ; Voss G; Hirsch VM; Richardson BA; Letvin NL; Hu SL; Johnson PR
    J Virol; 2004 Jun; 78(11):5983-95. PubMed ID: 15140996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis.
    Spencer DA; Goldberg BS; Pandey S; Ordonez T; Dufloo J; Barnette P; Sutton WF; Henderson H; Agnor R; Gao L; Bruel T; Schwartz O; Haigwood NL; Ackerman ME; Hessell AJ
    Nat Commun; 2022 Feb; 13(1):662. PubMed ID: 35115533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.
    Ziani W; Bauer A; Lu H; Wang X; Wu X; Bar KJ; Li H; Liu D; Shaw GM; Veazey RS; Xu H
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus.
    Garber DA; Guenthner P; Mitchell J; Ellis S; Gazumyan A; Nason M; Seaman MS; McNicholl JM; Nussenzweig MC; Heneine W
    AIDS; 2021 Aug; 35(10):1567-1574. PubMed ID: 33966028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.
    Parsons MS; Lloyd SB; Lee WS; Kristensen AB; Amarasena T; Center RJ; Keele BF; Lifson JD; LaBranche CC; Montefiori D; Wines BD; Hogarth PM; Swiderek KM; Venturi V; Davenport MP; Kent SJ
    Sci Transl Med; 2017 Aug; 9(402):. PubMed ID: 28794282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.
    Nakane T; Nomura T; Shi S; Nakamura M; Naruse TK; Kimura A; Matano T; Yamamoto H
    PLoS One; 2013; 8(9):e73453. PubMed ID: 24039947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.